-
Security Type
-
CAFES
-
Categories
-
Technology, Healthcare & Medical
-
Min Investment
-
$250
-
Expected Close Date
-
April 30, 2023
-
Target Raise
-
$50.00K-$400.00K
-
No. Investors
-
30
-
Security Price
-
$1
- Number of Employees
- 1
- Cash
- $19,884
- Revenue
- $0
- Short Term Debt
- $0
- Cost of Goods
- $0
- Long Term Debt
- $0
- Net Income
- $-22,116
Key Deal Facts
The Clinical Trials Market is currently worth ~$47 billion, with 10% CAGR through 2026
30% of Trial Budget is spent on Patient Recruitment yet >80% trials fail to meet recruitment target
Sieve relieves administrative bottleneck in trial recruitment by using AI enabled automation
Upfront visibility & automation reducing > 90% enrollment and > 25% trial timelines
Expand trial access to research naïve community physicians (participation today ~ 5%-7%)
Enhance diversity and decentralization in Clinical Trials
Successful commercial pilots completed with intent to continued paid use by the clients
Ongoing commercial collaboration with multiple research networks & healthcare groups
Management Team / Advisory Board Bios
Arti B Co-Founder & CEODentist/Clinical Researcher with 12+yrs of experience
Exhibited success in:
-structuring and implementing innovative solutions
-operational execution of commercial and
technology strategies
-initiating & leading corporate growth initiatives, Sameer Bhoite Co-Founder & CTO-Engineer | MS | MBA with 20+ yrs in Technology development & management
-Leader of multi-disciplinary global technology teams
-Serial entrepreneur
-Exhibited success in corporate execution of commercial and technology strategies, John Neal Strategic Advisor-30+ yrs in Clinical Research
-Founder-CEO of PCRS global site network
-Former Chair-ACRP (Association of Clinical Research Professionals)
-Former COO, CFO
-Speaker | Mentor
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation
Security Description
A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.
